The big headline with Pfizer is that it will have to deal with revenue declines from drugs facing patent expirations over the next few years. That's normal, since new drugs are given a time-limited ...

Nike’s latest hire isn’t a retail veteran or a company insider like CEO Elliott Hill. Rather, he comes from the pharmaceutical industry.

Continuing with ongoing trial that combines drug with Keytruda Plans to explore using the drug with other experimental treatments Shares fall 1% June 22 (Reuters) - Pfizer (PFE.N), opens new tab said ...

Matthew Herper covers medical innovation — both its promise and its perils. Pfizer said Monday that an experimental drug it hoped could replace a widely used chemotherapy in one of the most common ...

Pfizer Inc. said an experimental drug failed to improve survival in patients with an advanced form of lung cancer that couldn’t be treated with surgery, dealing a setback to the closely watched ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for predicting human pharmacokinetics”, in the ...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced topline results from the Phase 3 SigVie-002 study (previously known as Be6A Lung-01) evaluating sigvotatug vedotin, an ...

July 13, 2026, 7:57 PM ESTHealth Care May 06, 2026, 6:58 AM ESTHealth Care April 05, 2026, 6:38 PM ESTHealth Care March 24, 2026, 4:09 PM ESTHealth Care March 18, 2026, 1:36 PM ESTHealth Care March 05 ...

BILLERICA, Mass., June 23, 2026--(BUSINESS WIRE)--Javelin Biotech today announced a landmark scientific publication, titled "Interconnected multi-microphysiological systems and PBPK modeling for ...